Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Therapeutic effects of ephrin B receptor 2 inhibitors screened by molecular docking on cutaneous squamous cell carcinoma
By
- AMS
posted
Apr 27, 2020 12:27 PM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
Adverse cutaneous effects of psychotropic medications
- AMS
Added Jan 10, 2014
Blog Entry
Stop the clock: new therapeutic strategy targets “old” cells to prevent ageing
- AMS
Added Jan 26, 2022
Blog Entry
The therapeutic effects of blocking IGF-R1 on mice model of skin cancer
- AMS
Added Jan 04, 2020
Blog Entry
Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses
- AMS
Added Mar 23, 2021
Blog Entry
Treatment of basal cell carcinomas and basaloid follicular hamartomas in basal cell nevus syndrome children and adolescents
- AMS
Added Nov 02, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic